Comparison of interleukin 2 and gamma-interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation
- PMID: 2164265
- DOI: 10.1097/00007890-199007000-00008
Comparison of interleukin 2 and gamma-interferon production by peripheral blood mononuclear cells in response to cytomegalovirus after marrow transplantation
Abstract
Forty-five patients were prospectively studied during the first 100 days after allogeneic marrow transplant to determine the relationship between cytomegalovirus-specific gamma-interferon and interleukin 2 production by peripheral blood mononuclear cells and CMV infection. IL-2 production was significantly lower than normal throughout the study period (P = 0.0001). In contrast, mitogen-induced gamma-interferon production was in the normal range by days 41-60 while CMV antigen induced gamma-interferon production by PBMC was normal by 81-100 days after transplant. Antibody- and complement-depletion studies showed that T4 helper cells were capable of gamma-interferon production in response to CMV antigen despite deficient IL-2 production. Neither gamma-interferon nor IL-2 production distinguished CMV-infected from uninfected patients. However, CMV-infected patients had significantly more T8 cytotoxic/suppressor cells than did uninfected patients by 81-100 days after transplant (P = 0.001). In vitro addition of IL-2 significantly increased gamma-interferon production by PBMC from patients with reduced production, suggesting that decreased gamma-interferon production may be related to deficient IL-2 production. Deficiencies in both CMV-specific IL-2 and gamma-interferon production may contribute to the high frequency and severity of CMV infection after marrow transplantation.
Similar articles
-
Different kinetics in anti-cytomegalovirus immunity reconstitution evaluated by lymphocyte proliferation and IFN-gamma production in allogeneic and autologous bone marrow transplantation.Acta Haematol. 2002;107(4):187-94. doi: 10.1159/000058313. Acta Haematol. 2002. PMID: 12053145
-
Cytomegalovirus aggravates the autoimmune phenomenon in systemic autoimmune diseases.Microb Pathog. 2018 Jul;120:132-139. doi: 10.1016/j.micpath.2018.04.041. Epub 2018 Apr 26. Microb Pathog. 2018. PMID: 29704668
-
Discordant cellular and humoral immune responses to cytomegalovirus infection in healthy blood donors: existence of a Th1-type dominant response.Int Immunol. 2001 Jun;13(6):785-90. doi: 10.1093/intimm/13.6.785. Int Immunol. 2001. PMID: 11369706
-
Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.Br J Haematol. 2005 Nov;131(4):472-9. doi: 10.1111/j.1365-2141.2005.05800.x. Br J Haematol. 2005. PMID: 16281937
-
Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.Hum Immunol. 2004 May;65(5):493-9. doi: 10.1016/j.humimm.2004.02.004. Hum Immunol. 2004. PMID: 15172449 Review.
Cited by
-
Enhanced cytomegalovirus infection of developing brain independent of the adaptive immune system.J Virol. 2002 Sep;76(17):8842-54. doi: 10.1128/jvi.76.17.8842-8854.2002. J Virol. 2002. PMID: 12163604 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical